NCT01913314View on ClinicalTrials.gov

A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

[^14C]-LY2835219

Administered as oral solution

Trial Locations (1)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01913314 - A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants | Biotech Hunter | Biotech Hunter